Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,287 public trials 1,279 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Active, Not Recruiting

SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines

NCT04705389

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
Locations
  • Department of Dermatology, Medical University of Vienna Vienna, Austria
  • University Hospital of Helsinki, Finland Helsinki, Finland
  • Dermatology Dept, Hospital University of Tours Tours, France
  • Translational Skin Cancer Research Essen, Germany
View Trial Details
Active, Not Recruiting

Neuroblastoma Maintenance Therapy Trial

NCT02679144

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • University of Alabama, Children's of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UCSF Benioff Children's Hospital Oakland- Oakland, California, United States
  • Rady Children's Hospital San Diego, California, United States
View all 48 locations
View Trial Details
Active, Not Recruiting

Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery

NCT06204159

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Pennsylvania, Department of Radiology, Interventional Radiology Division Philadelphia, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma

NCT03224767

Conditions
BRAF V600E Mutation Present, Craniopharyngioma, Neoplasms, +5 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Sutter Cancer Centers Radiation Oncology Services-Auburn Auburn, California, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • Mills-Peninsula Medical Center Burlingame, California, United States
View all 106 locations
View Trial Details
Active, Not Recruiting

Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PN

NCT05309668

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations
  • Research Site Akron, Ohio, United States
  • Research Site Philadelphia, Pennsylvania, United States
  • Research Site Houston, Texas, United States
  • Research Site Richmond, Virginia, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3

NCT05916313

Conditions
Glioma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations
  • University of California Irvine Orange, California, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • Salzburg Cancer Research Institute Salzburg, Austria
  • Universitätsklinikum Frankfurt Frankfurt, Germany
View Trial Details

Related conditions